Emerging nutraceuticals provider Neutra Corp. NTRR -6.25% announced today that the company has placed its initial order for two new all-natural male enhancement supplements in order to move forward with clinical trials.

NTRR is working to produce a safe and effective alternative to prescription male enhancers such as Viagra, which can cause many unpleasant side effects. Clinical trials will be a crucial step toward breaking into the multi-billion-dollar sexual enhancement industry.

"The two formulas we'll be testing contain all-natural ingredients intended to increase sex drive, boost testosterone levels, support prostate health and improve circulation," said NTRR President Michael-Shane Henderson. "Once the supplements arrive from the manufacturer, we'll assemble a clinical testing group and begin studying their effects in order to fine-tune products that we feel will have the best chance of breakthrough success in the booming male enhancement sector worldwide."

As with its other product offerings under development, NTRR will also study how Bio-energy infusion could significantly boost the supplements potency naturally.

Neutra Corp. is developing these and other innovative products to compete in the fast-growing nutraceuticals industry alongside Herbalife Ltd. HLF 0.00% , Vitamin Shoppe VSI -2.34% , Nutraceutical International Corp. NUTR -1.08% and Schiff Nutrition International Inc. .

For more information on NTRR's nutraceuticals initiative, please visit www.neutracorp.com/investors .

Follow NTRR on Twitter at www.twitter.com/neutracorp .

About Neutra Corp.

Neutra Corp. ( www.neutracorp.com ) is a healthy lifestyle company that specializes in the development and marketing of nutritional supplements, nutrient boosters, herbal remedies and other natural wellness solutions. The company is currently working to produce a full range of products to address every component of a healthy lifestyle, including muscle building, weight loss and general wellness through a daily nutrition regimen. For investing information and performance data, please visit www.neutracorp.com/investors .

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

SOURCE: Neutra Corp.